CAR-engineered cell therapies: current understandings and future perspectives
Abstract Chimeric antigen receptor (CAR)–engineered cell therapies represent a significant breakthrough in immunotherapy, initially in cancer and now expanding into diverse clinical fields. While originally developed for oncology, these platforms are increasingly being adapted for non-malignant cond...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2026-01-01
|
| Colecção: | Molecular Biomedicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s43556-025-00401-4 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|